Features | Partner Sites | Information | LinkXpress
Sign In
RANDOX LABORATORIES
Bio-Rad Diabetes Division
AB Sciex

Methylation-Based Biomarker Indicates Chemo Resistance of Colorectal Cancer

By Labmedica International staff writers
Posted on 02 Feb 2012
Hypermethylation of the TFAP2E gene was correlated with nonresponsiveness of colorectal cancer to a commonly used chemotherapeutic agent.

In a study involving more than 200 patients in four independent cohorts, Prof. Ebert at the University of Heidelberg (Germany) and his team demonstrated that hypermethylation of the TFAP2E gene was correlated with nonresponsiveness of colorectal cancer to the commonly used chemotherapeutic agent 5-fluorouracil (5-FU). The study was reported in the January 2012 edition of the New England Journal of Medicine.

Using a combination of data from cancer cell lines and patient samples, the authors demonstrated that this effect was potentially mediated through up-regulation of the DKK4 gene, previously implicated in 5-FU resistance. Resistance to treatment was observed with 5-FU based chemotherapy or 5-FU chemotherapy combined with radiation, indicating that TFAP2E methylation may be a valuable biomarker for response prediction in either setting.

The study demonstrates the growing role that biomarkers can play in the management of cancer and other diseases. Prof. Ebert commented: “In practical terms, we believe this study demonstrates the potential that novel DNA methylation biomarkers may have in improving the selection of therapies for this deadly disease. A prospective validation of the marker is, however, still required.”

Epigenomics AG (Berlin, Germany and Seattle, WA, USA) scientists believe that the study demonstrates the potential of TFAP2E and other biomarkers identified in Epigenomics’ DNA methylation discovery pipeline in supporting clinical decision making.

Epigenomics’ lead product, Epi proColon, is a blood-based test for the early detection of colorectal cancer, which is currently marketed in Europe and is in development for the United States.

Related Links:

University of Heidelberg
Epigenomics AG



PURITAN MEDICAL
DiagCor Bioscience
77 ELEKTRONIKA
comments powered by Disqus
Sekisui Diagnostics

Channels

Clinical Chemistry

view channel
Image: The Cobas 6000 Multipurpose Clinical Laboratory analyzer (Photo courtesy of Roche Diagnostics).

Low Density Lipoprotein Apolipoprotein-B Assay Validated

The relationship between apolipoprotein-B (Apo-B) concentration and the risk of developing cardiovascular disease (CVD) is more robust than the relationship between low density lipoprotein cholesterol... Read more

Microbiology

view channel
Image: IC 3D technology rapidly detects bacterial infection in blood samples (Photo courtesy of University of California, Irvine).

DNA-Based Droplet System Rapidly Detects Bacterial Infection in the Bloodstream

A new test for bacterial infection in the bloodstream is based on an innovative DNA labeling and particle counting system. Investigators at the University of California, Irvine (USA) recently described... Read more

Industry News

view channel

Collaboration to Bring Personalized Cancer Care to Singapore

A German company specializing in cancer diagnosis will be extending its expertise in personalized care to the health care market in Singapore. New Oncology (Cologne, Germany) announced recently that it has entered into a collaboration agreement with the National Cancer Centre Singapore (Singapore). New Oncology will... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.